Heyholder
‹ Back to the disclosure you were reading

Hanmi Pharm. Co., Ltd. Q3 business update IR via Sangsangin Securities NDR, one-on-one meetings

Hanmi Pharm. Co., Ltd.· Investor Relations Event

AI summary · Not investment advice

Hanmi Pharm will hold one-on-one in-person meetings with domestic institutional investors on November 3 as part of a Sangsangin Securities NDR.

Key facts

IR date and time
Nov 3, 2026
Venue
Seoul
Audience
Domestic institutional investors
Purpose
Participation in Sangsangin Securities NDR (Non-Deal-Roadshow)
Format
One-on-one in-person meetings
Main topics
Explanation of key Q3 2026 business results, Q&A
Sponsor
Sangsangin Securities
Materials posting date
Oct 30, 2026
Materials location
https://www.hanmi.co.kr/about/investor-relations/ir/event/list.hm

Earlier Investor Relations Event filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.10.30Investor Relations Event—
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.